Kiniksa Pharmaceuticals Financials

Values in thousands	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	$202,127	$180,855	$156,797	$137,785
Gross Profit	111,031	97,264	85,763	76,127
EBITDA	23,736	27,541	20,518	13,617
EBIT	23,269	27,157	20,160	13,272
Net Income	14,199	18,435	17,832	8,539
Net Change In Cash	202,127	180,855	156,797	137,785
Free Cash Flow	53,260	33,006	27,925	22,225
Cash	165,596	174,858	192,037	157,132
Basic Shares	78,979	78,027	77,942	76,145

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$677,564	$423,239	$270,259	$220,180
Gross Profit	370,150	362,329	213,735	197,285
EBITDA	90,422	-43,921	-22,855	12,175
EBIT	88,868	-45,616	-25,196	9,773
Net Income	59,005	-43,193	14,084	183,363
Net Change In Cash	677,564	423,239	270,259	220,180
Cost of Revenue				245
Free Cash Flow	25,412	25,412	13,171	5,702
Cash	165,596	183,581	107,954	122,715
Basic Shares	78,979	71,424	71,922	70,421